Genelux Ownership | Who Owns Genelux?
Genelux Ownership Summary
Genelux is owned by 19.19% institutional investors, 11.40% insiders, and 69.41% retail investors. Woodward diversified capital is the largest institutional shareholder, holding 4.86% of GNLX shares.
GNLX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Genelux | 19.19% | 11.40% | 69.41% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Woodward diversified capital | 1.84M | 4.86% | $7.75M |
| Vanguard group | 1.42M | 3.74% | $5.96M |
| Bleichroeder lp | 714.00K | 1.88% | $2.05M |
| Blackrock funding, inc. /de | 379.89K | 1.00% | $1.60M |
| Geode capital management | 353.84K | 0.93% | $1.49M |
| Flputnam investment management | 300.29K | 0.79% | $1.26M |
| Alyeska investment group | 285.00K | 0.75% | $817.95K |
| Global retirement partners | 228.68K | 0.60% | $960.44K |
| Provident wealth management | 155.67K | 0.41% | $653.81K |
| Lpl financial | 109.78K | 0.29% | $461.06K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Woodward diversified capital | 1.84M | 3.61% | $7.75M |
| Bleichroeder lp | 714.00K | 0.50% | $2.05M |
| Lifesteps financial | 105.17K | 0.28% | $441.72K |
| Provident wealth management | 155.67K | 0.20% | $653.81K |
| 5t wealth | 24.10K | 0.04% | $101.22K |
| Global retirement partners | 228.68K | 0.02% | $960.44K |
| Flputnam investment management | 300.29K | 0.02% | $1.26M |
| Beacon capital management | 19.12K | 0.01% | $80.29K |
| Liberty wealth management | 16.55K | 0.01% | $69.50K |
| Falcon wealth planning | 22.00K | 0.01% | $92.40K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Flputnam investment management | 300.29K | 0.02% | 263.13K |
| Woodward diversified capital | 1.84M | 3.61% | 65.81K |
| Blackrock funding, inc. /de | 379.89K | - | 54.91K |
| Geode capital management | 353.84K | 0.00% | 35.02K |
| Marshall wace, llp | 32.22K | 0.00% | 32.22K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Heights capital management | - | - | -238.37K |
| Mai capital management | 31.99K | 0.00% | -204.56K |
| Omers administration | - | - | -79.70K |
| Paloma partners management | - | - | -50.00K |
| Miracle mile advisors | - | - | -40.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Mariner | 30.03K | 0.00% | 30.03K | $86.19K |
| Eversource wealth advisors | 150.00 | - | 150.00 | $630.00 |
| Citigroup | 1.00 | - | 1.00 | $4.00 |
Sold Out
| Holder | Change |
|---|---|
| Allworth financial lp | -162.00 |
| Coldstream capital management | -175.00 |
| Tower research capital llc (trc) | -592.00 |
| Coppell advisory solutions | -3.00K |
| Simplex trading | -6.35K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 59 | -21.33% | 7,281,681 | -0.23% | 19 | 4.39% | 25 | -46.81% | 12 | 9.09% |
| Mar 31, 2025 | 74 | 29.82% | 7,269,064 | 49.24% | 20 | 9.55% | 46 | 130.00% | 11 | -42.11% |
| Dec 31, 2024 | 57 | 1.79% | 4,870,849 | -6.84% | 14 | 6.44% | 20 | -4.76% | 19 | 11.76% |
| Sep 30, 2024 | 56 | -22.22% | 5,228,245 | -26.41% | 15 | 2.64% | 21 | -48.78% | 17 | -5.56% |
| Jun 30, 2024 | 72 | 9.09% | 7,104,517 | 18.07% | 23 | 4.76% | 41 | 7.89% | 18 | 20.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 12, 2025 | Ryder Sean | General Counsel | Sell | $13.07K |
| May 12, 2025 | Zindrick Thomas | President and CEO | Sell | $31.43K |
| May 12, 2025 | Yu Yong | VP, Clinical Trial Operations | Sell | $16.29K |
| May 12, 2025 | Cappello Joseph | VP, Pharmaceutical Development | Sell | $13.83K |
| May 12, 2025 | Smalling Ralph | Head of Regulatory | Sell | $3.68K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | 5 |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | 12 |
GNLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools